Back to Trades
Other4
Avalyn Pharma Inc.
AVLN
Total Value
$0
Company Information
- Company Name
- Avalyn Pharma Inc.
- Ticker Symbol
- AVLN
- CIK
- 0001540171
Insider Information
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- May 1, 2026
- Transaction Date
- May 1, 2026
- Accession Number
- 0001193125-26-201863
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | 1,275,486 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Derivative | 20,482,289 | — | C | — |
| May 1, 2026 | Derivative | 4,060,259 | — | C | — |
Footnotes
- (F1)Immediately prior to the closing of the Issuer's initial public offering, each share of Series C-1 Convertible Preferred Stock and Series D Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted into shares of the Issuer's Common Stock on a 19.2417-for-one basis. The Preferred Stock had no expiration date.